What it is
Methaqualone is a sedative-hypnotic, chemically unrelated to barbiturates or benzodiazepines but with similar effects. It was prescribed for insomnia and anxiety and as a muscle relaxant. A standard Quaalude tablet held 300 mg. It was first made in India in 1951 during research into malaria drugs. In 1972 it was the sixth best-selling sedative in the US.
How it works
Like other depressants, methaqualone boosts GABA, the brain's main calming signal. That produces relaxation and drowsiness and, at higher doses, euphoria and loss of coordination. Its half life is long (20 to 60 hours), so repeated doses build up. Tolerance develops quickly, which pushes users toward larger and more dangerous doses.
How it is used
- "Luding out": taken with wine or other alcohol to deepen sedation
- Sought for a false reputation as a "love drug"
- Obtained from "stress clinics" with little or no exam
- In South Africa today: crushed and smoked with cannabis (the "white pipe")
Effects and warning signs
- Drowsiness, slurred speech, poor coordination, euphoria
- Impaired judgment and impulsive behavior
- Overdose: slowed breathing, seizures, coma
- Withdrawal resembles barbiturate withdrawal, including seizures
The Labb MQL test
An MQL result is a Non-Negative screen until a laboratory confirms it. A confirmed positive in the US is rare and worth a careful MRO review. MQL is a separate strip. Methaqualone is not detected by the benzodiazepine (BZO) or barbiturate (BAR) strips. For someone using counterfeit "Quaaludes," the BZO and FTY strips are usually the ones that matter.
| Kit | Specimen | Cutoff (ng/mL) |
|---|---|---|
| eTest Cup UA:18C SVT | Urine | 300 |
| eTest Cup UA:23A SVT | Urine | 300 |
This profile is educational and does not replace a package insert, laboratory guidance or medical advice. A rapid test result is a Non-Negative screen until a laboratory confirms it.
